tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNYNF Stock Latest News

Trump announces pacts with nine pharma companies to lower drug prices
The FlyTrump announces pacts with nine pharma companies to lower drug prices
18h ago
BMY
GSK
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
PremiumThe Fly
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
20h ago
AZN
BMY
Sanofi anticipates delay in U.S. regulatory review of tolebrutinib in nrSPMS
PremiumThe Fly
Sanofi anticipates delay in U.S. regulatory review of tolebrutinib in nrSPMS
5d ago
SNY
Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study
PremiumThe Fly
Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study
5d ago
SNY
Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks
PremiumRatings
Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks
5d ago
SNY
Sanofi’s SAR445399 Study: A Potential Breakthrough in Hidradenitis Suppurativa Treatment
PremiumCompany AnnouncementsSanofi’s SAR445399 Study: A Potential Breakthrough in Hidradenitis Suppurativa Treatment
6d ago
SNYNF
Sanofi’s Amlitelimab Study: A New Hope for Atopic Dermatitis Treatment?
Premium
Company Announcements
Sanofi’s Amlitelimab Study: A New Hope for Atopic Dermatitis Treatment?
6d ago
SNYNF
Sanofi’s Amlitelimab Study Termination: Implications for Investors
Premium
Company Announcements
Sanofi’s Amlitelimab Study Termination: Implications for Investors
6d ago
SNYNF
Sanofi’s Dupilumab Study Completion: Implications for Asthma Treatment and Market Impact
PremiumCompany Announcements
Sanofi’s Dupilumab Study Completion: Implications for Asthma Treatment and Market Impact
6d ago
SNYNF
Sanofi says Qfitlia, Cablivi approved in China for rare hematologic diseases
PremiumThe Fly
Sanofi says Qfitlia, Cablivi approved in China for rare hematologic diseases
9d ago
SNY
Sanofi price target lowered to EUR 100 from EUR 102 at HSBC
PremiumThe Fly
Sanofi price target lowered to EUR 100 from EUR 102 at HSBC
10d ago
SNY
Guggenheim downgrades Sanofi on lack of near-term pipeline catalysts
PremiumThe Fly
Guggenheim downgrades Sanofi on lack of near-term pipeline catalysts
11d ago
SNY
Sanofi downgraded to Neutral from Buy at Guggenheim
PremiumThe FlySanofi downgraded to Neutral from Buy at Guggenheim
11d ago
SNY
Sanofi downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Sanofi downgraded to Neutral from Overweight at JPMorgan
12d ago
SNY
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
Premium
The Fly
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
15d ago
F
GM
FDA shift in drug study requirements sends trial runners lower
PremiumThe Fly
FDA shift in drug study requirements sends trial runners lower
16d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe Fly
FDA to reduce number of trials required for drug approvals, STAT reports
16d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe Fly
FDA to reduce number of trials required for drug approvals, STAT reports
16d ago
AZN
BMY
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
PremiumThe Fly
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
18d ago
AZN
BMY
Vaccine committee considers changes to childhood schedule, NY Times reports
PremiumThe FlyVaccine committee considers changes to childhood schedule, NY Times reports
18d ago
AZN
BMY
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
Premium
The Fly
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
19d ago
B
BX
Prasad email a headwind for vaccine manufacturers, says BofA
Premium
The Fly
Prasad email a headwind for vaccine manufacturers, says BofA
19d ago
GSK
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >